cyc 202 has been researched along with calpain in 5 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (calpain) | Trials (calpain) | Recent Studies (post-2010) (calpain) |
---|---|---|---|---|---|
979 | 7 | 393 | 7,019 | 25 | 2,422 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackerley, S; Brownlees, J; Kesavapany, S; Lau, KF; Leigh, PN; McLoughlin, DM; Miller, CC; Shaw, CE | 1 |
Kerokoski, P; Pirttilä, T; Salminen, A; Soininen, H; Suuronen, T | 1 |
Camins, A; Canudas, AM; Crespo-Biel, N; Gutiérrez-Cuesta, J; Melchiorri, D; Nicoletti, F; Pallàs, M | 1 |
Auladell, C; Beas-Zarate, C; Camins, A; Folch, J; Junyent, F; Pallàs, M; Pizarro, JG; Verdaguer, E | 1 |
He, CX; Hu, F; Huang, HZ; Li, K; Liu, D; Liu, FF; Wang, JZ; Xie, AJ; Zhu, LQ | 1 |
5 other study(ies) available for cyc 202 and calpain
Article | Year |
---|---|
p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
Topics: Alzheimer Disease; Animals; beta Catenin; Calpain; Cerebral Cortex; CHO Cells; Cricetinae; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Cytoskeletal Proteins; Enzyme Inhibitors; Humans; Kidney; Membrane Proteins; Nerve Degeneration; Nerve Tissue Proteins; Phosphorylation; Presenilin-1; Protein Binding; Purines; Rats; Roscovitine; Trans-Activators | 2001 |
Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
Topics: Acetylcysteine; Adenosine Triphosphate; Animals; Animals, Newborn; Brain Chemistry; Calpain; Cells, Cultured; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Cysteine Endopeptidases; Embryo, Mammalian; Enzyme Inhibitors; Hippocampus; Multienzyme Complexes; Nerve Tissue Proteins; Neurons; Okadaic Acid; Phosphorylation; Proteasome Endopeptidase Complex; Purines; Rats; Rats, Wistar; Roscovitine | 2002 |
Regulation of GSK-3beta by calpain in the 3-nitropropionic acid model.
Topics: Amino Acid Chloromethyl Ketones; Aminophenols; Animals; Calpain; Caspases; Cell Survival; Cells, Cultured; Convulsants; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Maleimides; Mice; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nitro Compounds; Propionates; Purines; Rats; Roscovitine; Signal Transduction; Time Factors | 2010 |
Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cells.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Calpain; Camptothecin; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Dipeptides; DNA Damage; DNA-Binding Proteins; Humans; Morpholines; Neuroblastoma; Protein Serine-Threonine Kinases; Purines; Pyrones; Roscovitine; Tumor Suppressor Proteins | 2011 |
Olfactory Deprivation Hastens Alzheimer-Like Pathologies in a Human Tau-Overexpressed Mouse Model via Activation of cdk5.
Topics: Alzheimer Disease; Animals; Calpain; Cholinergic Neurons; Cyclin-Dependent Kinase 5; Dendrites; Disease Models, Animal; Enzyme Activation; Humans; Mice; Olfactory Bulb; Phosphorylation; Purines; Roscovitine; Septal Nuclei; Solubility; tau Proteins; Tauopathies | 2016 |